Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Cardiac transplantation in Friedreich Ataxia: Extended follow-up.

McCormick A, Shinnick J, Schadt K, Rodriguez R, Addonizio L, Hirano M, Perlman S, Lin KY, Lynch DR.

J Neurol Sci. 2017 Apr 15;375:471-473. doi: 10.1016/j.jns.2017.01.027. Epub 2017 Jan 10.

PMID:
28109580
2.

Friedreich Ataxia: Hypoplasia of Spinal Cord and Dorsal Root Ganglia.

Koeppen AH, Becker AB, Qian J, Feustel PJ.

J Neuropathol Exp Neurol. 2017 Feb 1;76(2):101-108. doi: 10.1093/jnen/nlw111.

PMID:
28082326
3.

Effects of genetic severity on glucose homeostasis in Friedreich ataxia.

Isaacs CJ, Brigatti KW, Kucheruk O, Ratcliffe S, Sciascia T, McCormack SE, Willi SM, Lynch DR.

Muscle Nerve. 2016 Nov;54(5):887-894. doi: 10.1002/mus.25136. Epub 2016 Aug 30.

PMID:
27061687
4.

Pharmacological treatments for Friedreich ataxia.

Kearney M, Orrell RW, Fahey M, Brassington R, Pandolfo M.

Cochrane Database Syst Rev. 2016 Aug 30;(8):CD007791. doi: 10.1002/14651858.CD007791.pub4. Review.

PMID:
27572719
5.

Cerebral and cerebellar grey matter atrophy in Friedreich ataxia: the IMAGE-FRDA study.

Selvadurai LP, Harding IH, Corben LA, Stagnitti MR, Storey E, Egan GF, Delatycki MB, Georgiou-Karistianis N.

J Neurol. 2016 Nov;263(11):2215-2223. Epub 2016 Aug 13.

PMID:
27522354
6.

Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia.

Costantini A, Laureti T, Pala MI, Colangeli M, Cavalieri S, Pozzi E, Brusco A, Salvarani S, Serrati C, Fancellu R.

J Neurol. 2016 Nov;263(11):2170-2178. Epub 2016 Aug 3.

7.

The significance of intercalated discs in the pathogenesis of Friedreich cardiomyopathy.

Koeppen AH, Becker AB, Feustel PJ, Gelman BB, Mazurkiewicz JE.

J Neurol Sci. 2016 Aug 15;367:171-6. doi: 10.1016/j.jns.2016.06.006. Epub 2016 Jun 4.

PMID:
27423584
8.

Abundance and Significance of Iron, Zinc, Copper, and Calcium in the Hearts of Patients With Friedreich Ataxia.

Kruger PC, Yang KX, Parsons PJ, Becker AB, Feustel PJ, Koeppen AH.

Am J Cardiol. 2016 Jul 1;118(1):127-31. doi: 10.1016/j.amjcard.2016.04.024. Epub 2016 Apr 20.

9.

The Effect of Piracetam on Friedreich Ataxia.

Elmal AD, Gündüz A, Uzun N, Apaydn H, Kzltan G.

Clin Neuropharmacol. 2016 May-Jun;39(3):159-60. doi: 10.1097/WNF.0000000000000148. No abstract available.

PMID:
27171570
10.

Dorsal root ganglia in Friedreich ataxia: satellite cell proliferation and inflammation.

Koeppen AH, Ramirez RL, Becker AB, Mazurkiewicz JE.

Acta Neuropathol Commun. 2016 May 3;4(1):46. doi: 10.1186/s40478-016-0288-5.

11.

Gastrocnemius and soleus spasticity and muscle length in Friedreich's ataxia.

Milne SC, Corben LA, Yiu E, Delatycki MB, Georgiou-Karistianis N.

J Clin Neurosci. 2016 Jul;29:29-34. doi: 10.1016/j.jocn.2016.01.011. Epub 2016 Mar 25.

PMID:
27021226
12.

Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy.

Crombie DE, Pera MF, Delatycki MB, Pébay A.

Int J Cardiol. 2016 Jun 1;212:37-43. doi: 10.1016/j.ijcard.2016.03.040. Epub 2016 Mar 21. Review.

PMID:
27019046
13.

Acquired Pulmonary Vein Isolation in a Patient with Friedreich Ataxia.

Zipse MM, Aleong RG.

Card Electrophysiol Clin. 2016 Mar;8(1):151-3. doi: 10.1016/j.ccep.2015.10.016. Epub 2016 Jan 13. Review.

PMID:
26920184
14.

Friedreich ataxia is not only a GAA repeats expansion disorder: implications for molecular testing and counselling.

Hoffman-Zacharska D, Mazurczak T, Zajkowski T, Tataj R, Górka-Skoczylas P, Połatyńska K, Kępczyński Ł, Stasiołek M, Bal J.

J Appl Genet. 2016 Aug;57(3):349-55. doi: 10.1007/s13353-015-0331-4. Epub 2016 Feb 23.

PMID:
26906906
15.

Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor.

Chutake YK, Lam CC, Costello WN, Anderson MP, Bidichandani SI.

Nucleic Acids Res. 2016 Jun 20;44(11):5095-104. doi: 10.1093/nar/gkw107. Epub 2016 Feb 20.

16.

Friedreich Ataxia and nephrotic syndrome: a series of two patients.

Shinnick JE, Isaacs CJ, Vivaldi S, Schadt K, Lynch DR.

BMC Neurol. 2016 Jan 12;16:3. doi: 10.1186/s12883-016-0526-2.

17.

Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia.

Galea CA, Huq A, Lockhart PJ, Tai G, Corben LA, Yiu EM, Gurrin LC, Lynch DR, Gelbard S, Durr A, Pousset F, Parkinson M, Labrum R, Giunti P, Perlman SL, Delatycki MB, Evans-Galea MV.

Ann Neurol. 2016 Mar;79(3):485-95. doi: 10.1002/ana.24595.

PMID:
26704351
18.

IFN-γ for Friedreich ataxia: present evidence.

Wells M, Seyer L, Schadt K, Lynch DR.

Neurodegener Dis Manag. 2015 Dec;5(6):497-504. doi: 10.2217/nmt.15.52. Epub 2015 Dec 4.

PMID:
26634868
19.

Fronto-cerebellar dysfunction and dysconnectivity underlying cognition in friedreich ataxia: The IMAGE-FRDA study.

Harding IH, Corben LA, Storey E, Egan GF, Stagnitti MR, Poudel GR, Delatycki MB, Georgiou-Karistianis N.

Hum Brain Mapp. 2016 Jan;37(1):338-50. doi: 10.1002/hbm.23034. Epub 2015 Oct 27.

PMID:
26502936
20.

Acoustic Analyses of Prolonged Vowels in Young Adults With Friedreich Ataxia.

Carson C, Ryalls J, Hardin-Hollingsworth K, Le Normand MT, Ruddy B.

J Voice. 2016 May;30(3):272-80. doi: 10.1016/j.jvoice.2015.05.008. Epub 2015 Oct 9.

PMID:
26454768

Supplemental Content

Loading ...
Support Center